Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Brief report: retrospective case series of oxcarbazepine for irritability/agitation symptoms in autism spectrum disorder.

Douglas JF, Sanders KB, Benneyworth MH, Smith JL, Dejean VM, McGrew SG, Veenstra-Vanderweele J.

J Autism Dev Disord. 2013 May;43(5):1243-7. doi: 10.1007/s10803-012-1661-2.

PMID:
22976374
2.

Yokukansan (TJ-54) for irritability associated with pervasive developmental disorder in children and adolescents: a 12-week prospective, open-label study.

Wake R, Miyaoka T, Inagaki T, Furuya M, Ieda M, Liaury K, Kishi K, Horiguchi J.

J Child Adolesc Psychopharmacol. 2013 Jun;23(5):329-36. doi: 10.1089/cap.2012.0108.

PMID:
23782127
3.

Preliminary investigation of lithium for mood disorder symptoms in children and adolescents with autism spectrum disorder.

Siegel M, Beresford CA, Bunker M, Verdi M, Vishnevetsky D, Karlsson C, Teer O, Stedman A, Smith KA.

J Child Adolesc Psychopharmacol. 2014 Sep;24(7):399-402. doi: 10.1089/cap.2014.0019. Epub 2014 Aug 5.

PMID:
25093602
4.

Antiepileptic medications in autism spectrum disorder: a systematic review and meta-analysis.

Hirota T, Veenstra-Vanderweele J, Hollander E, Kishi T.

J Autism Dev Disord. 2014 Apr;44(4):948-57. doi: 10.1007/s10803-013-1952-2. Review.

PMID:
24077782
5.

A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder.

Marcus RN, Owen R, Kamen L, Manos G, McQuade RD, Carson WH, Aman MG.

J Am Acad Child Adolesc Psychiatry. 2009 Nov;48(11):1110-9. doi: 10.1097/CHI.0b013e3181b76658.

PMID:
19797985
6.

A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders.

Posey DJ, Guenin KD, Kohn AE, Swiezy NB, McDougle CJ.

J Child Adolesc Psychopharmacol. 2001 Fall;11(3):267-77.

PMID:
11642476
7.

Pharmacological management in children and adolescents with pervasive developmental disorder.

Sung M, Fung DS, Cai Y, Ooi YP.

Aust N Z J Psychiatry. 2010 May;44(5):410-28. doi: 10.3109/00048670903493330.

PMID:
20047454
8.

Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders.

Hollander E, Chaplin W, Soorya L, Wasserman S, Novotny S, Rusoff J, Feirsen N, Pepa L, Anagnostou E.

Neuropsychopharmacology. 2010 Mar;35(4):990-8. doi: 10.1038/npp.2009.202. Epub 2009 Dec 9.

9.

Aripiprazole monotherapy in children and young adolescents with pervasive developmental disorders: a retrospective study.

Masi G, Cosenza A, Millepiedi S, Muratori F, Pari C, Salvadori F.

CNS Drugs. 2009;23(6):511-21. doi: 10.2165/00023210-200923060-00005.

PMID:
19480469
10.

Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.

Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, Dunbar F.

Pediatrics. 2004 Nov;114(5):e634-41. Epub 2004 Oct 18.

PMID:
15492353
11.

STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study.

Erickson CA, Veenstra-Vanderweele JM, Melmed RD, McCracken JT, Ginsberg LD, Sikich L, Scahill L, Cherubini M, Zarevics P, Walton-Bowen K, Carpenter RL, Bear MF, Wang PP, King BH.

J Autism Dev Disord. 2014 Apr;44(4):958-64. doi: 10.1007/s10803-013-1963-z.

PMID:
24272415
12.

Case series: use of ziprasidone for maladaptive symptoms in youths with autism.

McDougle CJ, Kem DL, Posey DJ.

J Am Acad Child Adolesc Psychiatry. 2002 Aug;41(8):921-7.

PMID:
12164181
13.

[Anticonvulsant mood stabilizers in the treatment of behavioral and psychological symptoms of dementia (BPSD)].

Pinheiro D.

Encephale. 2008 Sep;34(4):409-15. doi: 10.1016/j.encep.2007.10.006. Epub 2008 Jan 14. Review. French.

PMID:
18922244
14.

Managing irritability and aggression in autism spectrum disorders in children and adolescents.

Robb AS.

Dev Disabil Res Rev. 2010;16(3):258-64. doi: 10.1002/ddrr.118. Review.

PMID:
20981764
15.

Oxcarbazepine in the treatment of child psychiatric disorders: a retrospective chart review.

Staller JA, Kunwar A, Simionescu M.

J Child Adolesc Psychopharmacol. 2005 Dec;15(6):964-9.

PMID:
16379517
16.

Aripiprazole for autism spectrum disorders (ASD).

Ching H, Pringsheim T.

Cochrane Database Syst Rev. 2012 May 16;5:CD009043. doi: 10.1002/14651858.CD009043.pub2. Review.

PMID:
22592735
17.

Brief report: an open-label study of the neurosteroid pregnenolone in adults with autism spectrum disorder.

Fung LK, Libove RA, Phillips J, Haddad F, Hardan AY.

J Autism Dev Disord. 2014 Nov;44(11):2971-7. doi: 10.1007/s10803-014-2144-4.

18.

Pharmacotherapy of irritability in pervasive developmental disorders.

Stigler KA, McDougle CJ.

Child Adolesc Psychiatr Clin N Am. 2008 Oct;17(4):739-52, vii-viii. doi: 10.1016/j.chc.2008.06.002. Review.

PMID:
18775367
19.

Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder.

King BH, Wright DM, Handen BL, Sikich L, Zimmerman AW, McMahon W, Cantwell E, Davanzo PA, Dourish CT, Dykens EM, Hooper SR, Jaselskis CA, Leventhal BL, Levitt J, Lord C, Lubetsky MJ, Myers SM, Ozonoff S, Shah BG, Snape M, Shernoff EW, Williamson K, Cook EH Jr.

J Am Acad Child Adolesc Psychiatry. 2001 Jun;40(6):658-65.

PMID:
11392343
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk